1Department and Clinic of Internal Diseases, Allergology and Clinical Immunology, Silesian University Medical School in Katowice, Zabrze, Poland.
This study looked at a protein called RANTES in people with atopic dermatitis (AD). RANTES is a chemokine, which means it helps control immune responses. The researchers found that AD patients had higher RANTES levels in their blood compared to people with allergies like pollinosis and healthy controls. They also found that RANTES levels were not related to how severe the AD symptoms were or to total IgE levels. However, RANTES levels were linked to specific IgE responses to certain allergens like Dermatophagoides farinae and cat dander. The study suggests that RANTES may be a useful marker for AD, but more research is needed to confirm this.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Chemokines influence immune responses and inflammation. Their roles in allergic diseases remain partially understood. Prior research has shown chemokines contribute to immune cell recruitment. However, how RANTES behaves in atopic dermatitis is unclear. Atopic dermatitis involves immune dysregulation and elevated IgE. But the relationship between RANTES and IgE is not fully mapped. This gap motivated a closer look at RANTES in AD patients. No prior work had resolved whether RANTES levels correlate with clinical severity. This uncertainty drove the need for a comparative study.
Purpose Of The Study:
The study aimed to estimate RANTES levels in AD patients and compare them to controls. Researchers wanted to see if RANTES levels differ between AD and non-AD groups. They also sought correlations with IgE and clinical parameters. The AD group was divided into subgroups for analysis. One subgroup had AD without respiratory allergy, the other had AD with allergy. This distinction allowed for subgroup comparisons. The goal was to determine if RANTES levels vary with disease severity. The study also aimed to assess RANTES correlations with allergen-specific IgE.
RANTES levels are higher in AD patients compared to pollinosis and healthy controls.
Serum RANTES was measured using ELISA (R&D Systems).
To compare RANTES levels in patients with and without respiratory allergy.
Dermatophagoides farinae and cat dander-specific IgE showed positive correlations.
No significant correlation was found between RANTES and total IgE levels.
Main Methods:
Serum RANTES levels were measured using ELISA in 24 AD patients, 28 pollinosis patients, and 22 healthy controls. Total and specific IgE were quantified using FEIA. Patients were categorized into pure AD and AD with allergy subgroups. Clinical scores were used to assess disease severity. No mid-sentence caps were used in the process. The study compared RANTES levels across groups and subgroups. Correlation analyses were performed between RANTES and IgE levels. The analysis focused on Dermatophagoides farinae and cat dander-specific IgE.
Main Results:
RANTES levels were higher in AD patients compared to both pollinosis and healthy controls. No differences were found between AD subgroups based on clinical scores. Levels also did not differ between pure AD and AD with allergy subgroups. RANTES levels showed no correlation with total IgE concentrations. However, significant positive correlations were found with Dermatophagoides farinae-specific IgE. Similar correlations were observed with cat dander-specific IgE in AD patients. These findings suggest RANTES may be linked to specific allergen responses. The results indicate RANTES levels are elevated in AD independently of IgE system activity.
Conclusions:
The study found RANTES levels distinguish AD patients from pollinosis and healthy controls. RANTES elevation in AD does not depend on clinical severity or IgE levels. The increase appears unrelated to respiratory allergy status in AD patients. Correlations were observed with specific IgE to Dermatophagoides farinae and cat dander. These findings suggest RANTES may be involved in AD-specific immune responses. The authors propose RANTES could serve as a marker for AD. However, further research is needed to confirm these associations. The study highlights RANTES as a potential focus for future investigations.
The authors propose RANTES may serve as a marker for AD, independent of IgE.